Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 1370
mi
from
Baltimore, MD
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 1370
mi
from
Baltimore, MD
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 024
mi
from
Boston, MA
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 024
mi
from
Boston, MA
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 60
mi
from
Las Vegas, NV
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 60
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 13025
mi
from
Camden, NJ
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 13025
mi
from
Camden, NJ
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 030
mi
from
New Brunswick, NJ
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 030
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 014
mi
from
Albany, NY
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 014
mi
from
Albany, NY
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 1355
mi
from
New York, NY
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 1355
mi
from
New York, NY
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 10188
mi
from
Patchogue, NY
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 10188
mi
from
Patchogue, NY
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 10781
mi
from
Durham, NC
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 10781
mi
from
Durham, NC
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site
mi
from
Cincinnati, OH
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site
mi
from
Tulsa, OK
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 1310
mi
from
Nashville, TN
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 1310
mi
from
Nashville, TN
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site
mi
from
Houston, TX
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 1343
mi
from
Salt Lake City, UT
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 1343
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 168
mi
from
Burlington, VT
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 168
mi
from
Burlington, VT
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 1323
mi
from
Kirkland, WA
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 1323
mi
from
Kirkland, WA
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site
mi
from
Seattle, WA
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 333
mi
from
Washington, D.C.,
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 333
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 10552
mi
from
Saint Louis, MO
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 10552
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated:  10/30/2017
Teva Investigational Site 11121
mi
from
Montreal,
Alternatives for Reducing Chorea in HD
An Open-Label, Long Term Safety Study of SD-809 ER in Subjects With Chorea Associated With Huntington Disease
Status: Enrolling
Updated: 10/30/2017
Teva Investigational Site 11121
mi
from
Montreal,
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Emory University
mi
from
Atlanta, GA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Indianda Spine Group
mi
from
Indianapolis, IN
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Indianda Spine Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Kansas University Medical Center
mi
from
Kansas City, KA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
John Hopkins University
mi
from
Baltimore, MD
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
John Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
New England Baptist Hospital
mi
from
Boston, MA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
New England Baptist Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Thomas Jefferson University and Rothman Institure Orthopaedics
mi
from
Philadelphia, PA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Thomas Jefferson University and Rothman Institure Orthopaedics
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Universty of Utah
mi
from
Salt Lake City, UT
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Universty of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
University of Virginia
mi
from
Charlottesville, VA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Harborview Medical Center
mi
from
Seattle, WA
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
University of Toronto
mi
from
Toronto,
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
University of Toronto
mi
from
Toronto,
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
Spine Education Research Institute
mi
from
Thornton, CO
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
Spine Education Research Institute
mi
from
Thornton, CO
Click here to add this to my saved trials
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated:  10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
An Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy
Status: Enrolling
Updated: 10/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Aurora, CO
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Daytona Beach, FL
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Louisville, KY
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Lewiston, ME
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Lewiston, ME
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Boston, MA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Omaha, NE
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
New York, NY
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Tulsa, OK
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Anaheim, CA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Fremont, CA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Fremont, CA
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Santa Barbara, CA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated:  11/1/2017
Clinical Research Facility
mi
from
Torrance, CA
Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With ICD and CRT-D Devices
Status: Enrolling
Updated: 11/1/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials